Cell proliferation-related markers in colorectal liver metastases: Correlation with patient prognosis

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2008-2014

  Costa, A ^a   Doci, R ^a   Mochen, C ^a   Bignami, P ^a   Faranda, A ^a   Gennari, L ^a   Silvestrini, R ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CANCER STAGING; CELL PROLIFERATION; COLORECTAL CANCER; FEMALE; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

EID: 0030900124     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2008     Document Type: Article

References (28)

1. Steele G Jr, Ravikumar TS: Resection of hepatic metastases from colorectal cancer: Biological perspectives. Ann Surg 210:127-138, 1989
2. Registry of Hepatic Metastases: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of indications for resection. Surgery 103:278-288, 1988
3. Nordlinger B, Jaeck D, Guiguet M, et al: Surgical resection of hepatic metastases. Multicentric retrospective study by the French Association of Surgery, in Nordlinger B, Jaeck D (eds): Treatment of Hepatic Metastases of Colorectal Cancer. Paris, France, Springer-Verlag, 1992, pp 129-146
4. Scheele J, Stangl R, Altendorf-Hofmann A, et al: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110:13-29, 1991
5. Doci R, Gennari L, Bignami P, et al: One hundred patients with hepatic metastases from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 78:797-801, 1991
6. Allred DC, Clark GM, Elledge R, et al: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200-206, 1993
7. Silvestrini R, Benini E, Daidone MG, et al: P53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965-970, 1993
8. Marks JR, Humphrey PA, Wu K, et al: Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer. Ann Surg 219:332-341, 1994
9. Silvestrini R: Cell kinetics: Prognostic and therapeutic implications in human tumours. Cell Prolif 27:579-596, 1994
10. Frank RE, Saclarides TJ, Leurgans S, et al: Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg 222:695-699, 1995
11. Öfner D, Riehemann K, Maier H, et al: Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: Correlation with tumour stage and patient survival. Br J Cancer 72:981-985, 1995
12. Silvestrini R, Daidone MG, Luisi A, et al: Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J Clin Oncol 13:697-704, 1995
13. Strauss GM, Kwiatkowski DJ, Harpole DH, et al: Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol 13:1265-1279, 1995
14. Tsushima K, Nagorney DM, Rainwater LM, et al: Prognostic significance of nuclear deoxyribonucleic acid ploidy patterns in resected hepatic metastases from colorectal carcinoma. Surgery 102:635-643, 1987
15. Silvestrini R, Costa A, Gennari L, et al: Cell kinetics of hepatic metastases as a prognostic marker in patients with advanced colorectal carcinoma. Hepato Pancreatic Biliary Surg 2:135-144, 1990
16. Yamaguchi A, Ishida T, Takegawa S, et al: Flow-cytometric analysis of colorectal cancer with hepatic metastases and its relationship to metastatic characteristics and prognosis. Oncology 47:478-482, 1990
17. Kastrinakis WV, Ramchurren N, Maggard M, et al: K-ras status does not predict successful hepatic resection of colorectal cancer metastasis. Arch Surg 130:9-14, 1995
18. Kastrinakis WV, Ramchurren N, Rieger KM, et al: Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression. Oncogene 11:647-652, 1995
19. Gennari L, Doci R, Bozzetti F, et al: Proposal for staging liver metastases, in Ellman K, Eccles SA (eds): Treatment of Metastases. Problems and Prospects. London, United Kingdom, Taylor & Francis, 1985, pp 35-40
20. Doci R, Bignami P, Montalto F, et al: Prognostic factors for survival and disease-free survival in hepatic metastases from colorectal cancer treated by resection. Tumori 81:143-146, 1995 (suppl)
21. 3H-thymidine labeling index: Cell proliferation of colorectal carcinoma in three different centers. Mod Pathol 5:627-631, 1991
22. Potten CS, Chadwick CA, Cohen AJ, et al: DNA damage in UV-irradiated human skin in vivo: Automated direct measurement by image analysis (thymidine dimers) compared with indirect measurement (unscheduled DNA synthesis) and protection by 5-methoxypsolaren. Int J Radiat Biol 63:313-324, 1993
23. Costa A, Marasca R, Valentinis B, et al: p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers. J Pathol 176:45-53, 1995
24. Silvestrini R, SICCAB Group for Quality Control of Cell Kinetic Determinations: Quality control for evaluation of the S-phase fraction by flow cytometry: A multicentric study. Cytometry 18:11-16, 1994
25. Sigurdsson H, Baldetorp B, Borg Å, et al: Flow cytometry in primary breast cancer: Improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels. Br J Cancer 62:786-790, 1990
26. Stangl R, Altendorf-Hofmann A, Charnley RM, et al: Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410, 1994
27. Pezzella F, Turley H, Kuzu I, et al: Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993
28. Silvestrini R, Veneroni S, Daidone MG, et al: The Bcl-2 protein: A prognostic indicator strongly related to P53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499-504, 1994